10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001564590-21-042149 |
| Period End Date | 20210630 |
| Filing Date | 20210806 |
| Fiscal Year | 2021 |
| Fiscal Period | Q2 |
| XBRL Instance | tmdx-10q_20210630_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
70 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Preferred Stock, No Par Value |
PreferredStockNoParValue
|
- | USD | Point-in-time |
| Preferred Stock, No Par Value |
PreferredStockNoParValue
|
- | USD | Point-in-time |
| Preferred Stock, Shares Authorized |
PreferredStockSharesAuthorized
|
25.00M | shares | Point-in-time |
| Preferred Stock, Shares Authorized |
PreferredStockSharesAuthorized
|
25.00M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$51.15M | USD | Point-in-time |
| Preferred Stock, Shares Issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$25.31M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$24.58M | USD | Point-in-time |
| Preferred Stock, Shares Issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Marketable securities |
MarketableSecuritiesCurrent
|
$86.94M | USD | Point-in-time |
| Marketable securities |
MarketableSecuritiesCurrent
|
$101.06M | USD | Point-in-time |
| Preferred Stock, Shares Outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Preferred Stock, Shares Outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Common Stock, No Par Value |
CommonStockNoParValue
|
- | USD | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$6.27M | USD | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$6.86M | USD | Point-in-time |
| Common Stock, No Par Value |
CommonStockNoParValue
|
- | USD | Point-in-time |
| Inventory |
InventoryNet
|
$13.01M | USD | Point-in-time |
| Inventory |
InventoryNet
|
$11.93M | USD | Point-in-time |
| Common Stock, Shares Authorized |
CommonStockSharesAuthorized
|
150.00M | shares | Point-in-time |
| Common Stock, Shares Authorized |
CommonStockSharesAuthorized
|
150.00M | shares | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$3.52M | USD | Point-in-time |
| Common Stock, Shares, Issued |
CommonStockSharesIssued
|
27.18M | shares | Point-in-time |
| Common Stock, Shares, Issued |
CommonStockSharesIssued
|
27.65M | shares | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$2.33M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$146.77M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$135.05M | USD | Point-in-time |
| Common Stock, Shares, Outstanding |
CommonStockSharesOutstanding
|
27.18M | shares | Point-in-time |
| Common Stock, Shares, Outstanding |
CommonStockSharesOutstanding
|
27.65M | shares | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$4.95M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$4.75M | USD | Point-in-time |
| Restricted cash |
RestrictedCashNoncurrent
|
$500.00K | USD | Point-in-time |
| Restricted cash |
RestrictedCashNoncurrent
|
$500.00K | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$6.00K | USD | Point-in-time |
| Other long-term assets |
OtherAssetsNoncurrent
|
$6.00K | USD | Point-in-time |
| Total assets |
Assets
|
$140.51M | USD | Point-in-time |
| Total assets |
Assets
|
$152.03M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$1.21M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$2.39M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesAndOtherLiabilities
|
$10.32M | USD | Point-in-time |
| Accrued expenses and other current liabilities |
AccruedLiabilitiesAndOtherLiabilities
|
$12.10M | USD | Point-in-time |
| Deferred revenue |
ContractWithCustomerLiabilityCurrent
|
$473.00K | USD | Point-in-time |
| Deferred revenue |
ContractWithCustomerLiabilityCurrent
|
$263.00K | USD | Point-in-time |
| Current portion of deferred rent |
DeferredRentCreditCurrent
|
$117.00K | USD | Point-in-time |
| Current portion of deferred rent |
DeferredRentCreditCurrent
|
$93.00K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$11.88M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$15.08M | USD | Point-in-time |
| Long-term debt, net of discount and current portion |
LongTermDebtNoncurrent
|
$34.92M | USD | Point-in-time |
| Long-term debt, net of discount and current portion |
LongTermDebtNoncurrent
|
$34.66M | USD | Point-in-time |
| Deferred rent, net of current portion |
DeferredRentCreditNoncurrent
|
$1.60M | USD | Point-in-time |
| Deferred rent, net of current portion |
DeferredRentCreditNoncurrent
|
$1.53M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$51.53M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$48.13M | USD | Point-in-time |
| Commitments and contingencies (Note 10) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, no par value; 150,000,000 shares authorized; 27,647,234 shares and 27,175,305 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively |
CommonStockValue
|
$505.93M | USD | Point-in-time |
| Common stock, no par value; 150,000,000 shares authorized; 27,647,234 shares and 27,175,305 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively |
CommonStockValue
|
$502.22M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-134.00K | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-95.00K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-398.23M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-416.82M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$113.76M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$88.98M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$54.65M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$97.67M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$46.68M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$103.89M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$152.03M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$140.51M | USD | Point-in-time |
Income Statement
70 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net revenue |
Revenues
|
$8.17M | USD | 1 Quarter |
| Net revenue |
Revenues
|
$3.39M | USD | 1 Quarter |
| Net revenue |
Revenues
|
$10.92M | USD | 2 Qtrs |
| Net revenue |
Revenues
|
$15.22M | USD | 2 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$4.15M | USD | 2 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$4.82M | USD | 2 Qtrs |
| Cost of revenue |
CostOfRevenue
|
$1.48M | USD | 1 Quarter |
| Cost of revenue |
CostOfRevenue
|
$2.58M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$5.59M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$10.40M | USD | 2 Qtrs |
| Gross profit |
GrossProfit
|
$1.91M | USD | 1 Quarter |
| Gross profit |
GrossProfit
|
$6.77M | USD | 2 Qtrs |
| Research, development and clinical trials |
ResearchAndDevelopmentExpense
|
$6.29M | USD | 1 Quarter |
| Research, development and clinical trials |
ResearchAndDevelopmentExpense
|
$10.83M | USD | 2 Qtrs |
| Research, development and clinical trials |
ResearchAndDevelopmentExpense
|
$10.13M | USD | 2 Qtrs |
| Research, development and clinical trials |
ResearchAndDevelopmentExpense
|
$3.90M | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$15.95M | USD | 2 Qtrs |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$9.16M | USD | 1 Quarter |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$12.52M | USD | 2 Qtrs |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$5.87M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$26.77M | USD | 2 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$22.65M | USD | 2 Qtrs |
| Total operating expenses |
OperatingExpenses
|
$15.46M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$9.77M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-7.86M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-9.87M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-15.88M | USD | 2 Qtrs |
| Loss from operations |
OperatingIncomeLoss
|
$-16.38M | USD | 2 Qtrs |
| Interest expense |
InterestExpense
|
$965.00K | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$1.92M | USD | 2 Qtrs |
| Interest expense |
InterestExpense
|
$2.04M | USD | 2 Qtrs |
| Interest expense |
InterestExpense
|
$1.00M | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$371.00K | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$-283.00K | USD | 2 Qtrs |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$171.00K | USD | 1 Quarter |
| Other income (expense), net |
OtherNonoperatingIncomeExpense
|
$588.00K | USD | 2 Qtrs |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-2.20M | USD | 2 Qtrs |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-1.46M | USD | 2 Qtrs |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-630.00K | USD | 1 Quarter |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-794.00K | USD | 1 Quarter |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-17.33M | USD | 2 Qtrs |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-8.49M | USD | 1 Quarter |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-18.57M | USD | 2 Qtrs |
| Loss before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
$-10.66M | USD | 1 Quarter |
| Provision for income taxes |
CurrentIncomeTaxExpenseBenefit
|
$16.00K | USD | 2 Qtrs |
| Provision for income taxes |
CurrentIncomeTaxExpenseBenefit
|
$10.00K | USD | 2 Qtrs |
| Provision for income taxes |
CurrentIncomeTaxExpenseBenefit
|
$6.00K | USD | 1 Quarter |
| Provision for income taxes |
CurrentIncomeTaxExpenseBenefit
|
$6.00K | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-10.67M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-7.92M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-17.35M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-18.59M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-8.85M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.50M | USD | 1 Quarter |
| Net loss per share attributable to common stockholders, basic |
EarningsPerShareBasic
|
$-0.36 | USD | 1 Quarter |
| Net loss per share attributable to common stockholders, basic |
EarningsPerShareBasic
|
$-0.68 | USD | 2 Qtrs |
| Net loss per share attributable to common stockholders, basic |
EarningsPerShareBasic
|
$-0.78 | USD | 2 Qtrs |
| Net loss per share attributable to common stockholders, basic |
EarningsPerShareBasic
|
$-0.39 | USD | 1 Quarter |
| Net loss per share attributable to common stockholders, diluted |
EarningsPerShareDiluted
|
$-0.39 | USD | 1 Quarter |
| Net loss per share attributable to common stockholders, diluted |
EarningsPerShareDiluted
|
$-0.78 | USD | 2 Qtrs |
| Net loss per share attributable to common stockholders, diluted |
EarningsPerShareDiluted
|
$-0.36 | USD | 1 Quarter |
| Net loss per share attributable to common stockholders, diluted |
EarningsPerShareDiluted
|
$-0.68 | USD | 2 Qtrs |
| Weighted average common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
23.33M | shares | 1 Quarter |
| Weighted average common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
27.62M | shares | 1 Quarter |
| Weighted average common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
27.50M | shares | 2 Qtrs |
| Weighted average common shares outstanding, basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
22.26M | shares | 2 Qtrs |
| Weighted average common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
27.50M | shares | 2 Qtrs |
| Weighted average common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
27.62M | shares | 1 Quarter |
| Weighted average common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
22.26M | shares | 2 Qtrs |
| Weighted average common shares outstanding, diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
23.33M | shares | 1 Quarter |
Cash Flow Statement
73 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
ProfitLoss
|
$-17.35M | USD | 2 Qtrs |
| Net loss |
ProfitLoss
|
$-18.59M | USD | 2 Qtrs |
| Net loss |
ProfitLoss
|
$-28.70M | USD | Annual |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$896.00K | USD | 2 Qtrs |
| Depreciation and amortization expense |
DepreciationDepletionAndAmortization
|
$745.00K | USD | 2 Qtrs |
| Stock-based compensation expense |
ShareBasedCompensation
|
$1.02M | USD | 2 Qtrs |
| Stock-based compensation expense |
ShareBasedCompensation
|
$2.92M | USD | 2 Qtrs |
| Non-cash interest expense and end of term accretion expense |
NonCashInterestAndEndOfTermAccretionExpense
|
$249.00K | USD | 2 Qtrs |
| Non-cash interest expense and end of term accretion expense |
NonCashInterestAndEndOfTermAccretionExpense
|
$264.00K | USD | 2 Qtrs |
| Net amortization of premiums on marketable securities |
AmortizationOfDebtDiscountPremium
|
$49.00K | USD | 2 Qtrs |
| Net amortization of premiums on marketable securities |
AmortizationOfDebtDiscountPremium
|
$767.00K | USD | 2 Qtrs |
| Unrealized foreign currency transaction (gains) losses |
ForeignCurrencyTransactionGainLossUnrealized
|
$-314.00K | USD | 2 Qtrs |
| Unrealized foreign currency transaction (gains) losses |
ForeignCurrencyTransactionGainLossUnrealized
|
$131.00K | USD | 2 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-2.13M | USD | 2 Qtrs |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-560.00K | USD | 2 Qtrs |
| Inventory |
IncreaseDecreaseInInventories
|
$1.41M | USD | 2 Qtrs |
| Inventory |
IncreaseDecreaseInInventories
|
$1.89M | USD | 2 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$1.21M | USD | 2 Qtrs |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$324.00K | USD | 2 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$938.00K | USD | 2 Qtrs |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-3.83M | USD | 2 Qtrs |
| Accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$1.99M | USD | 2 Qtrs |
| Accrued expenses and other current liabilities |
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
$660.00K | USD | 2 Qtrs |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$219.00K | USD | 2 Qtrs |
| Deferred revenue |
IncreaseDecreaseInContractWithCustomerLiability
|
$848.00K | USD | 2 Qtrs |
| Deferred rent |
IncreaseDecreaseInDeferredCharges
|
$46.00K | USD | 2 Qtrs |
| Deferred rent |
IncreaseDecreaseInDeferredCharges
|
$-623.00K | USD | 2 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-12.87M | USD | 2 Qtrs |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-16.71M | USD | 2 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$397.00K | USD | 2 Qtrs |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$273.00K | USD | 2 Qtrs |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$63.64M | USD | 2 Qtrs |
| Purchases of marketable securities |
PaymentsToAcquireMarketableSecurities
|
$45.46M | USD | 2 Qtrs |
| Proceeds from sales and maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$36.02M | USD | 2 Qtrs |
| Proceeds from sales and maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$58.81M | USD | 2 Qtrs |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-28.01M | USD | 2 Qtrs |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$13.08M | USD | 2 Qtrs |
| Payments of public offering costs and other financing costs |
PaymentsOfStockIssuanceCosts
|
$339.00K | USD | 2 Qtrs |
| Proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions |
ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions
|
$75.67M | USD | 2 Qtrs |
| Proceeds from issuance of common stock upon exercise of stock options |
ProceedsFromStockOptionsExercised
|
$167.00K | USD | 2 Qtrs |
| Proceeds from issuance of common stock upon exercise of stock options |
ProceedsFromStockOptionsExercised
|
$585.00K | USD | 2 Qtrs |
| Proceeds from issuance of common stock in connection with employee stock purchase plan |
ProceedsFromStockPlans
|
$197.00K | USD | 2 Qtrs |
| Proceeds from issuance of common stock in connection with employee stock purchase plan |
ProceedsFromStockPlans
|
$211.00K | USD | 2 Qtrs |
| Proceeds from Paycheck Protection Program loan |
ProceedsFromPaycheckProtectionProgramLoan
|
$2.25M | USD | 2 Qtrs |
| Repayment of Paycheck Protection Program loan |
RepaymentOfPaycheckProtectionProgramLoan
|
$2.25M | USD | 2 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$75.69M | USD | 2 Qtrs |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$796.00K | USD | 2 Qtrs |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$-273.00K | USD | 2 Qtrs |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$89.00K | USD | 2 Qtrs |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$31.06M | USD | 2 Qtrs |
| Net increase in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$733.00K | USD | 2 Qtrs |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$51.65M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$20.59M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$25.81M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$25.08M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$51.65M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$20.59M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$25.81M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$25.08M | USD | Point-in-time |
| Transfers of inventory to property and equipment |
InventoryTransferToPropertyPlantAndEquipment
|
$765.00K | USD | 2 Qtrs |
| Transfers of inventory to property and equipment |
InventoryTransferToPropertyPlantAndEquipment
|
$78.00K | USD | 2 Qtrs |
| Purchases of property and equipment included in accounts payable and accrued expenses |
CapitalExpendituresIncurredButNotYetPaid
|
$70.00K | USD | 2 Qtrs |
| Purchases of property and equipment included in accounts payable and accrued expenses |
CapitalExpendituresIncurredButNotYetPaid
|
$47.00K | USD | 2 Qtrs |
| Offering costs included in accounts payable and accrued expenses |
OfferingCostsIncludedInAccountsPayableAndAccruedExpenses
|
$409.00K | USD | 2 Qtrs |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$51.15M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$25.31M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$24.58M | USD | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalents
|
$500.00K | USD | Point-in-time |
| Restricted cash |
RestrictedCashAndCashEquivalents
|
$500.00K | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$51.65M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$20.59M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$25.81M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash, end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$25.08M | USD | Point-in-time |
Stockholders Equity
42 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Discounts and issuance costs of stock issued |
StockIssuanceCostsAndDiscounts
|
$628.00K | USD | 1 Quarter |
| Balance |
StockholdersEquity
|
$113.76M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$88.98M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$54.65M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$97.67M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$46.68M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$103.89M | USD | Point-in-time |
| Issuance of common stock upon the exercise of common stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$213.00K | USD | 1 Quarter |
| Issuance of common stock upon the exercise of common stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$92.00K | USD | 1 Quarter |
| Issuance of common stock upon the exercise of common stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$75.00K | USD | 1 Quarter |
| Issuance of common stock upon the exercise of common stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$372.00K | USD | 1 Quarter |
| Issuance of common stock in connection with employee stock purchase plan |
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
$197.00K | USD | 1 Quarter |
| Issuance of common stock in connection with employee stock purchase plan |
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
$211.00K | USD | 1 Quarter |
| Issuance of common stock in public offering,net of discounts and issuance costs |
StockIssuedDuringPeriodValueNewIssues
|
$75.04M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$631.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$385.00K | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$1.81M | USD | 1 Quarter |
| Stock-based compensation expense |
AdjustmentsToCommonStockShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$1.11M | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-26.00K | USD | 2 Qtrs |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-42.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-2.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$16.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-29.00K | USD | 2 Qtrs |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-27.00K | USD | 1 Quarter |
| Unrealized gains (losses) on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$64.00K | USD | 2 Qtrs |
| Unrealized gains (losses) on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$213.00K | USD | 1 Quarter |
| Unrealized gains (losses) on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-10.00K | USD | 2 Qtrs |
| Unrealized gains (losses) on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-18.00K | USD | 1 Quarter |
| Unrealized gains (losses) on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$8.00K | USD | 1 Quarter |
| Unrealized gains (losses) on marketable securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-149.00K | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-10.67M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-7.92M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-17.35M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-18.59M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-8.85M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.50M | USD | 1 Quarter |
| Balance |
StockholdersEquity
|
$113.76M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$88.98M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$54.65M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$97.67M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$46.68M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$103.89M | USD | Point-in-time |
Comprehensive Income
30 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
- | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-10.67M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-7.92M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-17.35M | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-18.59M | USD | 2 Qtrs |
| Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
- | USD | 1 Quarter |
| Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
- | USD | 2 Qtrs |
| Net loss |
NetIncomeLoss
|
$-8.85M | USD | 1 Quarter |
| Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
- | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-8.50M | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-26.00K | USD | 2 Qtrs |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-42.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-2.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$16.00K | USD | 1 Quarter |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-29.00K | USD | 2 Qtrs |
| Foreign currency translation adjustment |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
$-27.00K | USD | 1 Quarter |
| Unrealized gains (losses) on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$64.00K | USD | 2 Qtrs |
| Unrealized gains (losses) on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$213.00K | USD | 1 Quarter |
| Unrealized gains (losses) on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-10.00K | USD | 2 Qtrs |
| Unrealized gains (losses) on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-18.00K | USD | 1 Quarter |
| Unrealized gains (losses) on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$8.00K | USD | 1 Quarter |
| Unrealized gains (losses) on marketable securities, net of tax of $0 |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-149.00K | USD | 1 Quarter |
| Total other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-39.00K | USD | 2 Qtrs |
| Total other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-45.00K | USD | 1 Quarter |
| Total other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-191.00K | USD | 1 Quarter |
| Total other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$38.00K | USD | 2 Qtrs |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-10.71M | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-17.31M | USD | 2 Qtrs |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-8.69M | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-18.62M | USD | 2 Qtrs |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.